课题基金 / 基金详情

ADVANCED DEVELOPMENT OF A VACCINE CANDIDATE FOR STAPHYLOCOCCUS AUREUS INFECTION

ADVANCED DEVELOPMENT OF A VACCINE CANDIDATE FOR STAPHYLOCOCCUS AUREUS INFECTION
金黄色葡萄球菌感染候选疫苗的高级开发
批准号:
10710588
负责人:
VILASACK THAMMAVONGSA
金额:
$111.91万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-09-21 至 2024-03-20

项目摘要

项目成果

VILASACK THAMMAVONGSA的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
To support the advanced development of candidate products for use following the intentional release of or in response to naturally occurring outbreaks of infectious diseases and emerging infectious diseases. This contract may support formulation and manufacture of the individual vaccine components, as well as stability testing, nonclinical immunogenicity and efficacy testing in animal models, IND enabling GLP toxicology, submission of an IND and clinical safety and efficacy evaluation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ADVANCED DEVELOPMENT OF A VACCINE CANDIDATE FOR STAPHYLOCOCCUS AUREUS INFECTION
  • 批准号:
    10923773
  • 项目类别:
  • 资助金额:
    $62.29万
  • 财政年份:
    2022
  • 负责人:
    VILASACK THAMMAVONGSA
  • 依托单位:
海外基金